S4 E24, Sarah DiSalvatore, Fractional SVP of Clinical Operations & Biotech Executive

<p>Leading with Purpose in Rare Disease with Sarah DiSalvatore</p><p><br></p><p>In this episode of <em>She Leads Biotech</em>, I’m joined by Sarah DiSalvatore, Fractional SVP of Clinical Operations &amp; Biotech Executive, for a conversation about leadership, rare disease, and the realities of bringing innovative therapies to patients.</p><p>Sarah shares her journey from bench research to executive leadership, why quality and compliance are fundamental to successful clinical development, and how fractional leadership is helping early-stage biotech companies build smarter and more efficiently.</p><p>We also discuss the deeply personal experience of becoming a rare disease parent, and how that has transformed the way Sarah approaches patient advocacy, programme development, and the importance of building centres of excellence for underserved communities.</p><p>A thoughtful conversation about resilience, strategy, and keeping patients at the centre of every decision.</p><p><u><strong>Chapters</strong></u></p><p>00:00 Introduction<br>02:00 A Childhood Dream of Medicine<br>06:00 From Bench Research to Clinical Operations<br>11:00 Why Quality and Compliance Matter<br>16:00 Growing into Leadership<br>20:00 The Rise of Fractional Executives<br>25:00 Becoming a Rare Disease Parent<br>30:00 How Personal Experience Changed Clinical Development<br>34:00 Building Centres of Excellence for Rare Diseases<br>38:00 The Future of Clinical Operations<br>42:00 Advice for Parents, Caregivers &amp; Leaders</p><p><br></p><p>#SheLeadsBiotech #RareDisease #ClinicalOperations #BiotechLeadership #GeneTherapy #WomenInBiotech #CNAUSAExecutiveSearch</p><p></p>